Product
Supplier
Encyclopedia
Inquiry
Home > News > Market Flash > Megalabs acquires majority stake in DS Laboratories

Megalabs acquires majority stake in DS Laboratories

ECHEMI 2024-06-12

Megalabs has acquired a majority stake in DS Laboratories, further enhancing Megalabs’ position in the global dermatology market and in the United States.

 

DS Labs will benefit from Megalabs’ distribution network and operational expertise, accelerating the development and delivery of new treatments around the world.

 

"Our mission has always been to improve patient outcomes through the science of dermatology. Joining Megalabs allows us to expand our reach and impact," said Fernando Tamez, Director of DS Labs.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Comment
Comment

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.